194 related articles for article (PubMed ID: 10207667)
21. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
Molina P; Pellín A; Navarro S; Boix J; Carda C; Llombart-Bosch A
Virchows Arch; 1999 Dec; 435(6):596-605. PubMed ID: 10628802
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
Wang H; Wang X; Wang CF
Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
[TBL] [Abstract][Full Text] [Related]
25. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
26. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.
Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493
[TBL] [Abstract][Full Text] [Related]
27. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.
Yoshida M; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Hiraoka N; Sekine S
Br J Cancer; 2015 Oct; 113(8):1244-8. PubMed ID: 26355235
[TBL] [Abstract][Full Text] [Related]
28. Phyllodes tumor (cystosarcoma phyllodes) of the breast. A clinicopathologic study of 45 cases.
Inoshita S
Acta Pathol Jpn; 1988 Jan; 38(1):21-33. PubMed ID: 2834912
[TBL] [Abstract][Full Text] [Related]
29. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
30. First case of transformation for breast fibroadenoma to high-grade malignant phyllodes tumor in an in vitro fertilization patient: misdiagnosis of recurrence, treatment and review of the literature.
Pacchiarotti A; Selman H; Gentile V; Pacchiarotti A; Milazzo GN; Lanzilotti G; Lofino S; Frati P
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2495-8. PubMed ID: 24089229
[TBL] [Abstract][Full Text] [Related]
31. [Recurrences and metastases of cystosarcoma phylloides (phylloid tumor, WHO). On the 150th birthday of a controversial diagnostic concept].
Bässler R; Zahner J
Geburtshilfe Frauenheilkd; 1989 Jan; 49(1):1-10. PubMed ID: 2537247
[TBL] [Abstract][Full Text] [Related]
32. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
33. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
Wang F; Jia Y; Tong Z
Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
[TBL] [Abstract][Full Text] [Related]
35. Recurring cystosarcoma phyllodes associated with breast carcinoma.
Stone-Tolin K; Pollak EW; Dorzab W; Printz J
South Med J; 1982 Jul; 75(7):881-4. PubMed ID: 6283677
[TBL] [Abstract][Full Text] [Related]
36. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
37. MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.
Hu Y; Li G; Wang L; Zhang L; Guan J; Wang J
Pathol Int; 2021 Dec; 71(12):814-822. PubMed ID: 34597441
[TBL] [Abstract][Full Text] [Related]
38. p53 and p16INK4A mutations during the progression of glomus tumor.
Güran S; Tali ET
Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
[TBL] [Abstract][Full Text] [Related]
40. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
